109P Prognostic impact of target-directed therapies in biliary tract cancer patients harboring molecular alterationsSilvia Camera, A. Casadei-Gardini, M. Rimini et al.|ESMO Open|2025Cited by 0
353P Prognostic role of metastatic sites in a worldwide population of patients with biliary tract cancer treated with cisplatin, gemcitabine, and durvalumabSilvia Camera, M. Persano, Mario Domenico Rizzato et al.|Annals of Oncology|2025Cited by 0